Michael Roderick Cook, MD¹, Roni Shouval, MD, PhD², Miguel-Angel Perales, MD³, Evandro Bezerra, MD⁴, Alex Niu, MD^5*, Saurabh Dahiya^6*, Loretta J. Nastoupil, MD⁷, Caron A Jacobson, MD, MMSc⁸, Elizabeth Lihua Elizabeth Budde, MD, PhD⁹, Amanda L. Olson, MD¹⁰, Brent R. Logan, PhD^11*, Zhen-Huan Hu, MPH^12*, Hai-Lin Wang, MPH^12*, Zhong-Cheng Luo, PhD^12*, Jenny J. Kim, MD, MS¹³, Harry W. Smith, BSc MSc^12*, Andrew Lee, MD^12*, Fang Sun, MD, PhD^12*, Marcelo Pasquini, MD, MS¹⁴ and Frederick L. Locke, MD¹⁵

¹Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Dana-Farber Cancer Institute, Boston, MA
⁹City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁰Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI
¹²Kite, a Gilead Company, Santa Monica, CA
¹³Kite Pharma, a Gilead company, Santa Monica, CA
¹⁴Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹⁵Department of Immunology, Moffitt Cancer Center, Tampa, FL

Jennifer L. Crombie, MD^1*, Loretta J. Nastoupil, MD², Charalambos Andreadis^3*, Iris Isufi⁴, Bradley Hunter^5*, Allison Winter, MD⁶, Brian Hess, MD⁷, Stefan K. Barta, MD⁸, Michael J. Frigault⁹, Maria Lia Palomba, MD¹⁰, Natalie S. Grover, MD¹¹, Michael D. Jain, MD, PhD¹², Tamara K. Moyo, MD^13*, Sagar S. Patel, MD¹⁴, Priyanka A Pophali, MD¹⁵, David Bernasconi^16*, Charimar Santiago Parrilla^17*, Amani Kitali, MBA, MPH, PMP^16*, Fei Fei Liu^16*, Mecide Gharibo, MD^16* and Marcelo Pasquini, MD, MS¹⁷

¹Dana Farber Cancer Institute, Boston, MA
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
⁴Yale University School of Medicine, New Haven, CT
⁵Intermountain LDS Hospital, Salt Lake City, UT
⁶Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁷Medical University of South Carolina, Charleston, SC
⁸Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁹Massachusetts General Hospital, Boston, MA
¹⁰Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹The University of North Carolina at Chapel Hill, Chapel Hill, NC
¹²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹³Atrium Health / Levine Cancer Institute, Charlotte, NC
¹⁴Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁵Carbone Cancer Center, University of Wisconsin, Madison, WI
¹⁶Bristol Myers Squibb, Princeton, NJ
¹⁷Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

Alison R Sehgal, MD¹, Daanish Hoda², Peter A Riedell, MD³, Nilanjan Ghosh, MD, PhD⁴, Mehdi Hamadani, MD⁵, Gerhard Hildebrandt^6*, John E. Godwin^7*, Patrick M. Reagan, MD⁸, Nina Wagner-Johnston, MD⁹, James Essell^10*, Rajneesh Nath^11*, Scott R. Solomon, MD¹², Rebecca Champion^13*, Edward Licitra^14*, Suzanne Fanning¹⁵, Neel K. Gupta¹⁶, Victor A Chow, MD^17*, Brenda Yuan^18*, Zhi Yang^17*, Ken Ogasawara^18*, Jerill Thorpe^17* and Leo I. Gordon, MD¹⁹

¹University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
²Intermountain Healthcare, Loveland Clinic for Blood Cancer Therapy, Salt Lake City, UT
³David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁴Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
⁶University of Missouri - Columbia, Columbia, MO
⁷Providence Cancer Center, Earle A. Chiles Research Institute, Portland, OR
⁸University of Rochester Medical Center, Rochester, NY
⁹Johns Hopkins Hospital, Baltimore, MD
¹⁰Oncology Hematology Care, Cincinnati, OH
¹¹Banner MD Anderson Cancer Center, Gilbert, AZ
¹²Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
¹³Norton Cancer Institute, Louisville, KY
¹⁴Astera Cancer Care, East Brunswick, NJ
¹⁵Prisma Health, Greenville, SC
¹⁶Stanford Cancer Center, Palo Alto, CA
¹⁷Bristol Myers Squibb, Seattle, WA
¹⁸Bristol Myers Squibb, Princeton, NJ
¹⁹Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

Andre Goy, MD¹, Caron A Jacobson, MD, MMSc², Ian W. Flinn, MD, PhD³, Brian T. Hill, MD⁴, Wen-Kai Weng, MD, PhD⁵, Luke Mountjoy, DO⁶, Oluwole Olalekan, MD, MBBS, MPH^7*, Dan Zheng, PhD^8*, Ana Nunes, PharmD^8*, Wangshu Zhang, PhD^8*, Rhine R. Shen, PhD^8*, Ioana Kloos, MD^8* and Michael L. Wang, MD⁹

¹Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
²Dana-Farber Cancer Institute, Boston, MA
³Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁵Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
⁶Colorado Blood Cancer Institute, Denver, CO
⁷Vanderbilt University Cancer Center, Nashville, TN
⁸Kite, a Gilead Company, Santa Monica, CA
⁹The University of Texas MD Anderson Cancer Center, Houston, TX

Swetha Kambhampati, MD¹, Nausheen Ahmed, MD², Mehdi Hamadani, MD³, Soyoung Kim, PhD^3*, Michael T. Hemmer, MS^4*, Natalie S. Grover, MD⁵, Mazyar Shadman, MD, MPH⁶, Amer Beitinjaneh, MD, MPH, MSc^7*, Elizabeth Lihua Elizabeth Budde, MD, PhD⁸, James Gerson, MD⁹, Caron A Jacobson, MD, MMSc¹⁰, Frederick L. Locke, MD¹¹, Dwivedy S. Nasta, MD^12*, Michael L. Wang, MD¹³, Wen-Kai Weng, MD, PhD¹⁴, Jiali Yan, MS^4*, Ana Nunes, PharmD^4*, David Dalton, PharmD^4*, James J. Wu, MPH, MSc^4*, Amina Abdeldaim, MD, MPH^4*, Zhen-Huan Hu, MPH^4*, Marcelo Pasquini, MD, MS³ and Alex F. Herrera, MD¹⁵

¹Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
³Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
⁴Kite, a Gilead Company, Santa Monica, CA
⁵Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁶Fred Hutchinson Cancer Center, Seattle, WA
⁷University of Miami, Miami, FL
⁸Department of Hematology and HCT, City of Hope, Duarte, CA
⁹University of Vermont, Burlington, VT
¹⁰Dana-Farber Cancer Institute, Boston, MA
¹¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹²Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
¹³The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
¹⁵City of Hope, Duarte, CA

Adam S Kittai, MD¹, David A. Bond, MD, BS², Ying Huang, MS, MA³, Seema A Bhat, MD¹, Emily Blyth, MD, PhD⁴, John C. Byrd, MD⁵, Julio C Chavez, MD⁶, Matthew S. Davids, MD, MMSc⁷, Jamie P Dela Cruz^7*, Mark R Dowling, MBBS, PhD^8*, Caitlyn Duffy^7*, Carrie I Ho, MD⁹, Caron A Jacobson, MD, MMSc¹⁰, Samantha M. Jaglowski, MD, MPH¹, Nitin Jain, MD¹¹, Kevin H Lin, MD^12*, Christine McCarthy, BS^13*, Erin M Parry, MD, PhD⁷, Manoj Rai, MD^14*, Kerry A Rogers, MD³, Aditi Saha, MBBS⁶, Levanto Schachter, DO, MS¹⁵, Hamish Scott, MD^8*, Jayastu Senapati, MD, MBBS, DM¹¹, Mazyar Shadman, MD, MPH⁹, Tanya Siddiqi, MD¹⁶, Deborah M. Stephens, DO¹⁷, Vinay Vanguru, MBBS, FRACP, FRCPA^18*, William G. Wierda, MD, PhD¹⁹, Omer Zulfa, MD^5*, Jennifer A. Woyach, MD³ and Philip A. Thompson, MBBS^20*

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
³Division of Hematology, The Ohio State University, Columbus, OH
⁴Westmead Hospital, Sydney, Australia
⁵Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
⁶Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁷Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
⁸Peter MacCallum Cancer Centre, Department of Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia
⁹Division of Medical Oncology, University of Washington, Seattle, WA
¹⁰Dana-Farber Cancer Institute, Boston, MA
¹¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Medicine, Brigham and Women’s Hospital, Boston, MA
¹³City of Hope National Medical Center, Duarte, CA
¹⁴Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Sciences University, Portland, OR
¹⁵Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹⁶City of Hope, Irvine, CA
¹⁷Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁸Institute of Haematology, Royal Prince Alfred Hospital, NSW, Australia
¹⁹The University of Texas MD Anderson Cancer Center, Houston, TX
²⁰Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia